Paola Martinelli
Boehringer Ingelheim
Vienna
Host: Wolfgang Mikulits
Programm
Oncology research at Boehringer Ingelheim Vienna: focus on targeted protein degradation
Paola Martinelli is a molecular biologist with over 15 years of experience in cancer research, including 6 years in industry. She currently leads exploratory projects in target identification and validation, as well as early drug discovery programs from lead identification to preclinical development. Her focus is on anti-cancer new chemical entities, particularly targeted protein degradation (TPD), with extensive expertise in in vitro pharmacology and early translational research.
She earned her PhD in Life Sciences at the European Institute of Oncology in Milan, with postdoctoral training in Italy and Spain. From 2014, she served as Junior Group Leader at the Medical University of Vienna, focusing on molecular mechanisms driving tumor progression and metastasis, particularly in pancreatic cancer, and co-coordinated the Pancreatic Cancer Unit at the Comprehensive Cancer Center of MedUni Vienna/AKH. She is the author/co-author of 16 scientific publications, recipient of multiple awards, and a successful grant applicant.